{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:55:14Z","timestamp":1787442914588,"version":"build-2736575974"},"reference-count":131,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.annder.2012.12.012","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T15:33:47Z","timestamp":1357918427000},"page":"183-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Anomalies pigmentaires induites par les traitements anticanc\u00e9reux. Premi\u00e8re partie\u00a0: les chimioth\u00e9rapies"],"prefix":"10.1016","volume":"140","author":[{"given":"V.","family":"Sibaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Fricain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2012.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM196406182702503","article-title":"Cyclophosphamide therapy in childhood neuroblastoma","volume":"270","author":"Thurman","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2012.12.012_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(75)92809-3","article-title":"Hyperpigmentation after cancer therapy","author":"O\u2019Doherty","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2012.12.012_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(83)70177-5","article-title":"Cutaneous complications of chemotherapeutic agents","volume":"9","author":"Bronner","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00001622-200203000-00012","article-title":"Cutaneous toxicities of cancer therapy","volume":"14","author":"Alley","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14740338.3.6.579","article-title":"Mucocutaneous side effects of antineoplastic chemotherapy","volume":"3","author":"Guillot","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.annder.2012.12.012_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00128071-200102040-00006","article-title":"Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment","volume":"2","author":"Dereure","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000441-200105000-00005","article-title":"Cutaneous reactions to chemotherapeutic agents","volume":"321","author":"Koppel","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.annder.2012.12.012_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","article-title":"Chemotherapeutic agents and the skin: an update","volume":"58","author":"Heidary n","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2005.11.004","article-title":"Dermatologic toxicity of chemotherapeutic agents","volume":"33","author":"Payne","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0055","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/1097-0142(19930501)71:9<2873::AID-CNCR2820710931>3.0.CO;2-6","article-title":"Ifosfamide-induced hyperpigmentation","volume":"71","author":"Terensi","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1097-0142(19940101)73:1<240::AID-CNCR2820730141>3.0.CO;2-6","article-title":"Ifosfamide-induced hyperpigmentation","volume":"73","author":"Yule","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0025-7125(16)30976-2","article-title":"Cutaneous side effects of cancer chemotherapy","volume":"70","author":"Hood","year":"1986","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.annder.2012.12.012_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0190-9622(08)80301-5","article-title":"Cutaneous pigmentation after daunorubicin chemotherapy","volume":"26","author":"Anderson","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1346-8138.1980.tb01993.x","article-title":"Busulfan hyperpigmentation: light and electron microscopic studies","volume":"7","author":"Adam","year":"1980","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1978.tb03587.x","article-title":"Cyclophosphamide-induced nail pigmentation","volume":"98","author":"Shah","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12029-009-9068-9","article-title":"Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer","volume":"39","author":"Vickers","year":"2008","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.det.2007.08.006","article-title":"Cutaneous reactions to chemotherapy: commonly seen, less described, little understood","volume":"26","author":"Sanborn","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2012.12.012_bib0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1468-3083.2007.02242.x","article-title":"Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an ederly vitiligo patient","volume":"21","author":"Tavares-Bello","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2005.10.027","article-title":"Pegylated liposomal doxorubicin (Lipo-Dox\u00ae) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynaecologic oncology group study with long-term follow-up","volume":"101","author":"Chou","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archderm.1995.01690140086015","article-title":"Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent","volume":"131","author":"Zimmerman","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1525-1470.1991.tb00867.x","article-title":"Discrete pigmentation after chemotherapy","volume":"8","author":"Singal","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(96)90725-2","article-title":"A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1alpha","volume":"35","author":"Prussick","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0120","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/archderm.1989.01670160072011","article-title":"Observations and proposed mechanism of N,N,N\u201d-triethylenethiophosphamide (thiothepa)-induced hyperpigmentation","volume":"125","author":"Horn","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1346-8138.1992.tb03218.x","article-title":"Blue-gray pigmentation in a patient receiving doxorubicin","volume":"19","author":"Konohana","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0130","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1578::AID-CNCR23>3.0.CO;2-W","article-title":"Localized cisplatin hyperpigmentation induced by pressure","volume":"77","author":"Al Lamki","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0135","first-page":"1753","article-title":"Pemetrexed-induced hyperpigmentation of the skin","volume":"31","author":"Schallier","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annder.2012.12.012_bib0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2230.2008.02896.x","article-title":"Cyclophosphamide-induced nail discoloration and skin hyperpigmentation: a rare presentation","volume":"34","author":"Chittari","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0145","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1111\/j.1365-2230.2009.03713.x","article-title":"Patterns of chromonychia during chemotherapy in patients with skin type V and outcome after 1year of follow-up","volume":"34","author":"Ranawaka","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/11537080-000000000-00000","article-title":"Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy","volume":"12","author":"Ziemer","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-4362.1991.tb05878.x","article-title":"Pigmentary effects from the protacted infusion of 5-fluorouracil","volume":"30","author":"Perlin","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2007.12.037","article-title":"Cutaneous effects of thiothepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation","volume":"58","author":"Rosman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1468-3083.2000.00037.x","article-title":"Bullous acral erythema and concomitant pigmentation on the face and occluded skin","volume":"14","author":"Ozkaya-Bayazit","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0170","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2010.04.021","article-title":"Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features","volume":"64","author":"Martorell-Calatayud","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1991.tb08621.x","article-title":"The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation","volume":"77","author":"Morgan","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2012.12.012_bib0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(77)93006-9","article-title":"Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation","volume":"1","author":"Kew","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2012.12.012_bib0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1346-8138.1988.tb03706.x","article-title":"Pigmented macules in patients treated with systemic 5-fluorouracil","volume":"15","author":"Cho","year":"1988","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archderm.1977.01640030125034","article-title":"Doxorubicin and unusual skin manifestations","volume":"113","author":"Law","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0195","first-page":"1167","article-title":"Effets secondaires cutan\u00e9o-muqueux des perfusions continues de 5-fluorouracile\u00a0: 12\u00a0observations","volume":"115","author":"Guillaume","year":"1988","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.1980.01640270033005","article-title":"Pigmentation with doxorubicin therapy","volume":"116","author":"Orr","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0205","first-page":"101","article-title":"Serious hand and foot syndrome in black patients treated with capecitabine: report of 3\u00a0cases and review of the literature","volume":"73","author":"Narasimhan","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2012.12.012_bib0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archderm.1984.01650380122026","article-title":"Hyperpigmentation with daunorubicin therapy","volume":"120","author":"Kelly","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/1120009X.1994.11741178","article-title":"Dermatological toxicity from chemotherapy containing 5-fluorouracil","volume":"6","author":"Leo","year":"1994","journal-title":"J Chemother"},{"key":"10.1016\/j.annder.2012.12.012_bib0220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaad.2005.01.123","article-title":"Marked and restricted cutaneous pigmentation induced by selective intra-arterial cisplatin infusion","volume":"54","author":"Yanagi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0225","first-page":"202","article-title":"Capecitabine-induced cutaneous hyperpigmentation: report of a case","volume":"1","author":"Pui","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0230","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clon.2009.02.007","article-title":"A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon","volume":"21","author":"Ghosal","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0235","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0190-9622(95)91271-1","article-title":"Cutaneous photosensitivity diseases induced by exogenous agents","volume":"33","author":"Gould","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0240","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaad.2008.05.018","article-title":"Toxic erythema of chemotherapy: a useful clinical term","volume":"59","author":"Bolognia","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.soncn.2006.04.007","article-title":"Chemotherapy and cutaneous toxicities: implications for oncology nurses","volume":"22","author":"Viale","year":"2006","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.annder.2012.12.012_bib0250","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2002.104509","article-title":"Generalized hyperpigmentation with daunorubicin chemotherapy","volume":"46","author":"Kroumpouzos","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0255","first-page":"439","article-title":"Hyperpigmentation induite par le busulfan\u00a0: une observation avec \u00e9tude ultrastructurale","volume":"126","author":"Simonart","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0560.1985.tb01613.x","article-title":"Cutaneous busulfan effect in patients receiving bone-marrow transplantation","volume":"12","author":"Hymes","year":"1985","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2012.12.012_bib0265","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2005.01.127","article-title":"Serpentine supravenous streaks induced by 5-fluorouracil","volume":"53","author":"Jain","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0190-9622(91)70280-F","article-title":"Unusual serpentine hyperpigmentation associated with 5-fluorouracil","volume":"25","author":"Vukelja","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1468-3083.2006.01952.x","article-title":"Multiple atypical naevus after systemic 5-fluorouracil","volume":"21","author":"Rodriguez-Blanco","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-4362.1995.tb01579.x","article-title":"Reticulate pigmentation due to 5-fluorouracil","volume":"34","author":"Allen","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0285","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ejon.2004.06.007","article-title":"Management of hand-foot syndrome in patients treated with capecitabine (Xeloda\u00ae)","volume":"8","author":"Lassere","year":"2004","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.annder.2012.12.012_bib0290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00128071-200910040-00006","article-title":"Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine","volume":"10","author":"Villalon","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D39207D9JR","article-title":"Longitudinal melanonychia induced by capecitabine","volume":"15","author":"Paravar","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2012.12.012_bib0300","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.annder.2011.06.012","article-title":"Hyperpigmentation \u00e0 la cap\u00e9citabine suivie de syndrome mains-pieds\u00a0: une nouvelle observation","volume":"139","author":"Agharbi","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0305","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(01)06650-8","article-title":"Clinical picture: leopard-like vitiligo with capecitabine","volume":"358","author":"Schmid-Wendtner","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2012.12.012_bib0310","first-page":"205","article-title":"Tegafur-induced acral hyperpigmentation","volume":"48","author":"Llistosella","year":"1991","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2012.12.012_bib0315","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2133.2004.06149.x","article-title":"Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug","volume":"151","author":"Fukushima","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D365M8X79P","article-title":"Doxorubicin-induced hyperpigmentation","volume":"14","author":"Abbasi","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2012.12.012_bib0325","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08358.x","article-title":"Daunorubicin-induced hyperpigmentation","volume":"151","author":"Pol","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2012.12.012_bib0330","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1468-3083.2000.00143.x","article-title":"Oral pigmentation","volume":"14","author":"Lenane","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0335","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2710.2009.01128.x","article-title":"Pharmacokinetics and its relation to toxicity of pegylated-liposomal doxorubicin in Chinese patients with breast tumours","volume":"35","author":"Xu","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.annder.2012.12.012_bib0340","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archderm.136.12.1475","article-title":"Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin","volume":"136","author":"Lotem","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0345","first-page":"901","article-title":"An intertrigo-like eruption from pegylated liposomal doxorubicin","volume":"5","author":"Korver","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0350","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jaad.2006.04.076","article-title":"Chemotherapy-induced toxic erythema under treatment with pegylated liposomal dororubicin: no restriction to palms and soles","volume":"58","author":"Ziemer","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0355","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archderm.143.11.1461","article-title":"Bleomycin-induced \u201cflagellate dermatitis\u201d","volume":"143","author":"Arseculeratne","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0360","first-page":"293","article-title":"Pigmentation cutan\u00e9e par la bl\u00e9omycine","volume":"77","author":"Moulin","year":"1970","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.annder.2012.12.012_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-4632.2007.03499.x","article-title":"Bleomycin-induced flagellate dermatitis","volume":"46","author":"Vuerstaek","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0370","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2006.07474.x","article-title":"Bleomycin and the skin","volume":"155","author":"Yamamoto","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0375","first-page":"285","article-title":"Bleomycin-induced flagellate pigmentation","volume":"68","author":"Nigro","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2012.12.012_bib0380","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-4632.2010.04755.x","article-title":"Bleomycin-induced flagellate dermatitis","volume":"50","author":"Wolf","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0385","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.revmed.2008.09.015","article-title":"L\u2019\u00e9ryth\u00e8me flagell\u00e9\u00a0: une complication rare de la bl\u00e9omycine","volume":"30","author":"Pasquet","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2012.12.012_bib0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMicm1002334","article-title":"Bleomycin-induced flagellate hyperpigmentation","volume":"363","author":"Ibrahimi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2012.12.012_bib0395","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.139.3.337","article-title":"Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris","volume":"139","author":"Abess","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0400","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1200\/JCO.2006.09.7691","article-title":"Bleomycin-induced flagellate erythema","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0405","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000018044","article-title":"Dermal sclerosis in the lesional skin of \u201cflagellate\u201d erythema (scratch dermatitis) induced by bleomycin","volume":"197","author":"Yamamoto","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2012.12.012_bib0410","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-2133.2005.06633.x","article-title":"Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0415","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/SMJ.0b013e3181ce0f5e","article-title":"Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy","volume":"103","author":"Geddes","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.annder.2012.12.012_bib0420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000247152","article-title":"Supravenous hyperpigmentation induced by vinorelbine","volume":"188","author":"Cecchi","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2012.12.012_bib0425","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2133.2000.03518.x","article-title":"Supravenous discoloration of the skin due to docetaxel treatment","volume":"142","author":"Schrivers","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0430","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1468-3083.2005.01088.x","article-title":"Persistent supravenous hyperpigmented eruption associated with docetaxel","volume":"19","author":"Aydogan","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D309M643S1","article-title":"Docetaxel -induced supravenous serpentine dermatitis","volume":"17","author":"Ghosh","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2012.12.012_bib0440","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000246423","article-title":"Chemotherapy-associated supravenous hyperpigmentation","volume":"192","author":"Baselga","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2012.12.012_bib0445","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1067\/mjd.2000.106239","article-title":"Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine","volume":"43","author":"Marcoux","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMicm0911228","article-title":"Serpentine supravenous hyperpigmentation","volume":"363","author":"Chan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2012.12.012_bib0455","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.143.12.1555","article-title":"Long-term follow-up of a patient with eruptive melanocytic nevi after Stevens-Johnson syndrome","volume":"143","author":"Gelfer","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0460","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.jaad.2004.08.009","article-title":"Eruptive navi of the palms and soles","volume":"52","author":"Woodhouse","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0465","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1989.01670150087015","article-title":"Eruptive dysplasic nevi associated with human immunodeficiency virus infection","volume":"125","author":"Duvic","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0190-9622(93)70008-H","article-title":"Excess melanocytic nevi in children with renal allografts","volume":"28","author":"Smith","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0475","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1365-2133.2006.07189.x","article-title":"Induction of eruptive benign melanocytic naevus by immune suppressive agents, including biologicals","volume":"154","author":"Bovenschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0480","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archdermatol.2010.145","article-title":"Eruptive naevus in a patient receiving cyclosporine A for psoriasis treatment","volume":"146","author":"Lopez","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0485","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1097\/MJT.0b013e3181d860f6","article-title":"Hand-foot hyperpigmentation skin lesions associated with combination gemcitabine-carboplatin (Gemcarbo) therapy","volume":"18","author":"Kleynberg","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.annder.2012.12.012_bib0490","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1111\/j.1365-2230.2009.03725.x","article-title":"Generalized eruptive lentiginosis induced by chemotherapy","volume":"35","author":"De","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0495","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1468-3083.2006.01952.x","article-title":"Multiple atypical naevi after systemic 5-fluorouracil","volume":"21","author":"Rodriguez-Blanco","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0500","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1525-1470.2007.00359.x","article-title":"Eruptive postchemotherapy in situ melanomas and dysplastic nevi","volume":"24","author":"Reutter","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0505","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.305.6857.799","article-title":"Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevus","volume":"305","author":"Baird","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2012.12.012_bib0510","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archdermatol.2008.623","article-title":"\u03b1-melanocyte-stimulating hormone-induced eruptive nevi","volume":"145","author":"Cardones","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0515","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0190-9622(03)02482-4","article-title":"Eruptive melanocytic nevi in patients with renal allografts: report of 10\u00a0cases with dermoscopic findings","volume":"49","author":"Alaibac","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0520","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.06.023","article-title":"Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy","volume":"54","author":"Piaserico","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0525","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(96)90661-1","article-title":"Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myeolocytic leukaemia: case report and review of the literature","volume":"35","author":"Richert","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0530","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/cncr.21404","article-title":"Increased incidence of melanoma in renal transplant recipients","volume":"104","author":"Hollenbeak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0535","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1468-3083.2002.00570_3.x","article-title":"Topotecan-induced cellulitis-like fixed drug eruption","volume":"16","author":"Senturk","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0540","first-page":"190","article-title":"Cutaneous fixed drug eruption to paclitaxel; a case report","volume":"21","author":"Baykal","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.annder.2012.12.012_bib0545","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0190-9622(96)80147-2","article-title":"Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption","volume":"34","author":"Young","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0550","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1365-2133.2000.03432.x","article-title":"Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel","volume":"142","author":"Chu","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0555","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000018132","article-title":"Nail changes secondary to docetaxel (Taxotere)","volume":"198","author":"Correia","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2012.12.012_bib0560","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00015550252948275","article-title":"Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment","volume":"82","author":"Chu","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2012.12.012_bib0565","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000248042","article-title":"Reticulate pigmentation due to bleomycin: light- and electron-microscopic studies","volume":"180","author":"Wright","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.annder.2012.12.012_bib0570","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000018132","article-title":"Nail changes secondary to docetaxel (taxotere)","volume":"198","author":"Correia","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2012.12.012_bib0575","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1684\/bdc.2011.1457","article-title":"Dermatologic side effects induced by new angiogenesis inhibitors","volume":"98","author":"Sibaud","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1016\/j.annder.2012.12.012_bib0580","first-page":"239","article-title":"Transverse melanonychia after radiation therapy","volume":"85","author":"Pellicane","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2012.12.012_bib0585","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-4362.1993.tb02745.x","article-title":"Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera","volume":"32","author":"Gropper","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0590","first-page":"128","article-title":"Hyperpigmentation after cancer chemotherapy","volume":"2","author":"Markenson","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2012.12.012_bib0595","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mjd.2002.120910","article-title":"Nail pigmentation caused by hydroxyurea: report of 9\u00a0cases","volume":"47","author":"Aste","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0600","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0190-9622(89)70324-8","article-title":"Longitudinal melanonychia (melanonychia striata): diagnosis and management","volume":"21","author":"Baran","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D381H8P24M","article-title":"Nail toxicity related to taxanes","volume":"9","author":"Mourad","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2012.12.012_bib0610","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1346-8138.2004.tb00636.x","article-title":"Topotecan-induced nail pigmentation","volume":"31","author":"Baykal","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0615","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.3.1.57","article-title":"Drug-induced nail abnormalities","volume":"3","author":"Piraccini","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.annder.2012.12.012_bib0620","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1468-3083.2006.01887.x","article-title":"Nail changes associated with chemotherapy in children","volume":"21","author":"Chen","year":"2007","journal-title":"J Eur Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0625","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00007611-197912000-00040","article-title":"Pigmentation of the tongue and mucous membranes associated with cancer chemotherapy","volume":"72","author":"Krutchik","year":"1979","journal-title":"South Med J"},{"key":"10.1016\/j.annder.2012.12.012_bib0630","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0253-7613.70401","article-title":"An unusual case of capecitabine hyperpigmentation: is hyperpigmentation a part of hand-foot syndrome or a separate entity?","volume":"42","author":"Vasudevan","year":"2010","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.annder.2012.12.012_bib0635","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1056\/NEJMicm1014268","article-title":"Images in clinical medicine. Chemotherapy-induced hyperpigmentation of the tongue","volume":"365","author":"Blaya","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2012.12.012_bib0640","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.2.5809.352-b","article-title":"Cyclophosphamide and pigmentation","volume":"1","author":"Harrison","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.annder.2012.12.012_bib0645","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-051X.2005.00646.x","article-title":"Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review","volume":"32","author":"Laporta","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.annder.2012.12.012_bib0650","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(95)90134-5","article-title":"Clofazimine: a review of its medical uses and mechanisms of action","volume":"32","author":"Arbiser","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.12.012_bib0655","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2000.106340","article-title":"Oral mucosal hyperpigmentation secondary to antimalarial drug therapy","volume":"90","author":"Kleinegger","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812013907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812013907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:00:32Z","timestamp":1758970832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963812013907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0151963812013907"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2012.12.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anomalies pigmentaires induites par les traitements anticanc\u00e9reux. Premi\u00e8re partie\u00a0: les chimioth\u00e9rapies","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2012.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}